Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies said yesterday that it is providing tools to Stemina Biomarker Discovery to accelerate its metabolomic research.

Agilent will provide Stemina with a 1290 Infinity UHPLC platform for the separation of stem cell metabolites, and a 6530 Q-TOF mass spec for the identification of metabolites. In addition, Agilent is providing Mass Profile Profession software for interpreting complex data generated from metabolomic research.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.